Speaker illustration

Doctor Anna Malgorzata Kozynacka

John Paul II Hospital, Krakow (Poland)

Transcoronary transfer of Wharton's jelly mesenchymal pluripotent stem cells in patients with chronic ischaemic heart failure shows safety and unprecedented high-grade myocardial uptake

Event: ESC Congress 2019

Topic: Imaging

Session: Treatment of the chronic heart failure

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb